Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study.
Chaigneau
L
L
Royer
B
B
Montange
D
D
Nguyen
T
T
Maurina
T
T
Villanueva
C
C
Demarchi
M
M
Borg
C
C
Fagnoni-Legat
C
C
Kantelip
J-P
JP
Pivot
X
X
D000042:Absorption; D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D013607:Tablets; D013810:Therapeutic Equivalency
D000964:Antimetabolites, Antineoplastic; D013607:Tablets; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil